Potential Impact of Low-Dose Methotrexate on Symptoms Associated With Myeloproliferative Neoplasms
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Haematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Low-Dose Methotrexate: Potential Clinical Impact on Haematological and Constitutional Symptoms in Myeloproliferative Neoplasms
Br. J. Haematol 2019 Sep 16;[EPub Ahead of Print], S Francis, S Thomas, R Luben, N Sousos, A Mead, JA Snowden, MP ZeidlerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.